Advances in Antiphospholipid (Hughes's) Syndrome

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 1, 1998, Pages 61-66

  Amengual, O ^a   Atsumi, T ^a   Khamashta, M A ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin antibodies; Lupus anticoagulant; Thrombosis; 2 glycoprotein I

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031972058     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Hughes GRV The antiphospholipid syndrome: ten years on. Lancet 1993; 342:341-4.
2. Khamashta M A, Asherson R A. Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. Br J Rheumatol 1995; 34:493-4.
3. Asherson R A. A "primary" antiphospholipid syndrome. J Rheumatol 1988; 15:1742-6.
4. Khamashta M A, Hughes G R V. Antiphospholipid antibodies and antiphospholipid syndrome Curr Opin Rheumatol 1995; 7:389-94.
5. Vianna J L, Khamashta M A, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med 1994; 96:3-9.
6. Stimmler M M, Coletti P M, Quismorio F P. Magnetic resonance imaging of the brain in neuropsyquiatric systemic lupus erythematosus Semin Arthritis Rheum 1993; 22:335-49.
7. Toubi E, Khamashta M A, Panarra A, Hughes GRV Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99:397-401.
8. Le T H, Wechesler B, Piette J C, Doumith R, Bellin M F, Papo T, et al. The antiphospholipid syndrome: A new cause of bilateral adrenal haemorrhage four cases Presse Med 1993; 22:249-54
9. Pelletier S, Landi B, Piette J C Ekert P, Coutellier A, Desmoulins C, et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 1994; 21:76-80
10. Hughson M D, McCarty-Farid G A, Brumback R A. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 1995; 26:716-24.
11. Ford S E, Kennedy L, Ford P M Climcopathologic correlations of antiphospholipid antibodies: an autopsy study. Arch Pathol Lab Med 1994; 118:491-5
12. Branch D W, Silver R M. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996; 5:409-13.
13. Branch D W. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994; 3:275-80.
14. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84:4203-8.
15. Herranz M T, Rivier G, Khamashta M A, Blaser K U, Hughes G R V. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus Arthritis Rheum 1994; 37:568-71.
16. Asherson R A, Derksen R, Harris E N, Hughes GRV. Chorea in systemic lupus and lupus-like disease: association with antiphospholipid antibodies. Semin Arthritis Rheum 1987; 16:253-9.
17. Levine S R, Brey R L Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5:347-53.
18. Alarcon-Segovia D, Deleze M, Oria C V, Sanchez-Guerrero J, Gomez-Pacheco L, Gabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68:353-65.
19. Tsakins D A, Kappos L, Reber G, Marber G A, Le Floch-Rohr J, Roux E, et al. Lack of association between antiphospholipid antibodies and migraine. Thromb Haemost 1993; 69:415-7
20. Khamashta M A, Cervera R, Asherson R A, Font J, Gil A, Coltart D J, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335:1541-4.
21. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93:1579-87.
22. Asherson R A The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19:508-12
23. Harris E N Antiphospholipid antibodies Br J Haematol 1990; 74:1-9.
24. Harris E N, Gharavi A E, Boey M L, Patel B M, Mackworth-Young C G, Loizou S, et al. Anti-cardiolipm antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii:1211-4.
25. Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56:193-9
26. Harns E N, Gharavi A E, Patel B M, Hughes GRV. Evaluation of the anti-cardiolipin antibody test. report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68:215-22.
27. Cervera R, Khamashta M A, Font J, Sebastiani G D, Gil A, Lavilla P, et al. Systemic lupus erythematosus: Clinical and immunological patterns of disease expression in a cohort of 1000 patients Medicine (Baltimore) 1993; 72:113-24.
28. Harris E N, Chan J K H, Asherson R A, Aber V R, Gharavi A E, Hughes G R V. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiohpin antibody test Arch Intern Med 1986; 146:2153-6.
29. Amengual O, Atsumi T, Khamashta M A, Koike T, Hughes G R V. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphosphohpid syndrome. Br J Rheumatol 1996; 35:1239-43.
30. McNeil H P, Simpson R J, Chesterman C N, Krihs S A. Anti-phospholipid antibodies are directed against a complex antigen that induces a lipidbinding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H).Proc Natl Acad Sci USA 1990; 87:4120-4
31. Galli M, Comfurius P, Maassen C, Hemker C, DeBaets M H, van Bredavriesman P J C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:952-3.
32. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-8.
33. Arvieux J, Roussel B, Jacob M C, Colomb M G. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 1991; 143:223-9.
34. Matsuura E, Igarashi Y, Yasuda T, Triplett D A, Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-62.
35. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S, et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1466-74.
36. Ichikawa K, Khamashta M, Koike T, Matsuura E, Hughes G R V Reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome to β2-glycoprotein I. Arthritis Rheum 1994; 37:1453-61.
37. Cabral A R, Amigo M C, Cabiedes J, Alarcón-Segovia D. The antiphospholipid/cofactor syndromes a primary variant with antibodies to β2-glycoprotein I but no antibodies detectable in standard antiphospholipid assay. Am J Med 1996; 101:472-81.
38. Roubey R A S. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39:1444-54.
39. Triplett D A. Assays for detection of antiphospholipid antibodies. Lupus 1994; 3:281-7
40. Roubey R A S, Pratt C W, Buyon J P, Winfield J B. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2 glycoprotein I. J Clin Invest 1992; 90:1100-4.
41. Arvieux J, Pouzol P, Roussel B, Jacob M C, Colomb M G. Lupus-like anticoagulant properties of murine monoclonal antibodies to β2-glycoprotein I. Br J Haematol 1992; 81 568-73.
42. Schousboe I, Rasmussen M S. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by β2-glycoprotein I and anti-β2-glycoprotein I. Thromb Haemost 1995; 73:798-804.
43. Bevers E M, Galli M, Barbui T, Comfurius P, Zwaal R F. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66:629-32.
44. Roubey R A S. Autoantibodies to phospholipid-binding plasma proteins a new view of lupus anticoagulants and other "antiphospholipid" antibodies. Blood 1994; 84:2854-67
45. Oosting J D, Derksen RHWM, Bobbink I W G, Hackeng T M, Bouma B N, de Groot P G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 1993; 81:2618-25.
46. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-annexin antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997; 54:209-13.
47. Arnout J. The pathogenesis of the antiphospholipid syndrome, a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996, 75:536-41.
48. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of β2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997; 107:569-73.
49. Khamashta M A. Management of thrombosis in the antiphospholipid syndrome. Lupus 1996; 5:463-6.
50. Lockshin M D. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993; 19:235-47.
51. Khamashta M A, Cuadrado M A, Mujic F, Taub N A, Hunt B J, Hughes G R V. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332:993-7.
52. Asherson R A, Baguley E, Pal C, Hughes G R V. Antiphospholipid syndrome: five year follow up. Ann Rheum Dis 1991; 50:805-10.
53. Gertner E, Lie J Y. Systemic therapy with fibrinolytic agents and heparin for recalcitrant non-healing cutaneous ulcer in the antiphospholipid syndrome. J Rheumatol 1994; 21:2159-61.
54. Zahavi J, Charach G, Schafer R, Toeg A, Zahavi M. Ischaemic necrotic toes associated with antiphospholipid syndrome and treated with iloprost Lancet 1993; 342:862.
55. Asherson R A, Cervera R. "Primary", "secondary" and other variants of the antiphospholipid syndrome. Lupus 1994; 3:293-8.
56. Lima F, Khamashta M A, Buchanan N M N, Kerstake S, Hunt B J, Hughes G R V. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14:131-8.
57. Hunt B J, Doughty H, Majumdar G, Copplestone A, Kerslake S, Buchanan N, et al. Thromboprophylaxis with low molecular heparin (fragmin) in high risk pregnancies. Thromb Haemost 1997; 77:39-43.